SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy

Authors :: Visar Vela
Anna Stelling-Germani
Alexandar Tzankov
Claudia Döring
Cheuk Ting Wu
Anne Müller
Sebastian Newrzela
Magdalena M. Gerlach
Sylvia Hartmann
University of Zurich
Source :: Haematologica
Publication Year :: 2020

Subjects :: business.industry
10061 Institute of Molecular Cancer Research
610 Medicine & health
Hematology
DNA Methylation
Hodgkin Disease
Smad1 Protein
Pharmacotherapy
Text mining
Promoter hypermethylation
Cancer research
Humans
Medicine
Hodgkin lymphoma
570 Life sciences
biology
Promoter Regions, Genetic
Letters to the Editor
business

Full Text Access

Tools